Hot Topics

GO2 for Lung Cancer Brings Patients and Advocates to Capitol Hill to Urge Action on the Nation’s Leading Cancer Killer

2026-02-27T12:48:37-06:00February 25th, 2026|Advocacy in Action, Hot Topics, News, Press Releases|

Lung Cancer Voices Summit Calls on Congress: Support Research. Save Lives.  Washington, D.C. — February 25, 2026 — On March 3, GO2 for Lung Cancer (GO2) will convene more than 200 people impacted by lung cancer on Capitol Hill for its annual Lung Cancer Voices Summit, elevating patient voices and [...]

FDA Clears eyonis LCS for Use in Lung Cancer Screening

2026-02-18T07:14:14-06:00February 18th, 2026|Hot Topics, News, Science and Research|

On February 6th, 2026, the U.S. Food and Drug Administration (FDA) approved Median Technologies’ eyonis Lung Cancer Screening (LCS), a medical device used for the combined detection and diagnosis of lung cancer. eyonis LCS is an AI-based technology designed to support the earlier detection of lung cancer by helping clinicians identify and characterize pulmonary (lung) nodules on low-dose CT (LDCT) scans.   In performance testing, eyonis LCS demonstrated a:   93.3% sensitivity, which means that if 100 [...]

Leptomeningeal Disease: What to Know and Why Expertise Matters

2026-02-04T15:59:01-06:00February 3rd, 2026|Hot Topics, Newsletter Articles, Science and Research, Your Community|

By Matthew Reiss, MSE, PhD, Manager, Precision Medicine & Navigation, GO2 for Lung Cancer  Hearing that cancer has spread to the brain or spinal cord can be a frightening, but very real outcome for many people living with lung cancer. While exact statistics are hard to pin down, recent studies suggest that about 10-40% of lung [...]

Go to Top